Aclarion raises ~$10.36M via registered direct offering of common stock and pre-funded warrants

Aclarion, Inc.

200,000 shares at $5.18 each; pre-funded warrants for 1.8M shares at $0.00001 exercise price.
Gross proceeds ~$10.36M; net to fund market development, Clarity Trial, product dev, and G&A.
Pre-funded warrants immediately exercisable with 4.99%/9.99% beneficial ownership limitation.
Closing expected Jan 9, 2026; Dawson James Securities is placement agent at 6.0% fee.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.